CARMAT invited to present at the Ladenburg Thalmann Healthcare Conference in New York
Paris, September 23, 2019 – 7.00 am CEST
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced its participation in the Ladenburg Thalmann Healthcare Conference on Tuesday, September 24, 2019 in New York (United States).
Stéphane Piat, Chief Executive Officer of CARMAT, will present the company at a plenary session from 2:30 pm to 2:55 pm (EDT) at the Sofitel Hotel (Track 4 – St. Germain III) in New York.
You can follow the presentation of CARMAT live on this link: